Handelsavisen
prelaunch
Companies Industrials 6092.T
60
6092.T Tokyo Stock Exchange Environmental Services & Equipment

EnBio Holdings Inc

¥723,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,08 %
Op margin
13,4 %
ROE
4,3 %
Net margin
14,0 %
Debt / equity
1,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

EnBio Holdings Inc provides industrial services, primarily in the environmental services and equipment sector, generating revenue through the provision of specialized industrial services.

Business. EnBio Holdings Inc (6092.T) is an environmental services and equipment company headquartered in Japan and listed on the Tokyo Stock Exchange. The firm operates within the Industrial & Commercial Services sector, focusing on industrial services and product sales. Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorIndustrials
Business sectorIndustrial & Commercial Services
IndustryEnvironmental Services & Equipment
ActivityIndustrial Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
4,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 6092.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 6092.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    EnBio Holdings Inc (6092.T) is an environmental services and equipment company headquartered in Japan and listed on the Tokyo Stock Exchange. The firm operates within the Industrial & Commercial Services sector, focusing on industrial services and product sales. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorIndustrials
    Business sectorIndustrial & Commercial Services
    IndustryEnvironmental Services & Equipment
    ActivityIndustrial Services
    AI synthesis
    GENERATED

    EnBio Holdings Inc maintains a capital structure with a debt-to-equity ratio of 1.01, indicating a balanced mix of debt and equity financing. The company's liquidity position is characterized by a current ratio of 1.99, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

    In terms of profitability, EnBio reports a return on equity (ROE) of 4.28% and a return on assets (ROA) of 1.88%. These figures are below the typical thresholds for strong performance in the industrial services sector, indicating that the company is generating modest returns relative to its equity and asset base.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks if the segment faces headwinds.

    Looking ahead, EnBio's growth trajectory is modest, with no specific revenue growth projections provided in the available data. The company's capital expenditures for the period were -1,079,075,000 JPY, indicating a reduction in investment in long-term assets, which may affect future growth potential.

    The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential challenges in maintaining liquidity without external financing. No dilution sources are identified in the available data, and the dilution risk is assessed as low.

    Recent financial filings and transcripts do not provide additional insights into the company's strategic direction or operational performance beyond what is disclosed in the financial snapshot. The company's last actual EPS was 55.90 JPY, and its last actual revenue was 10,668,080,000 JPY, according to analyst estimates.

    Key takeaways
    • EnBio Holdings Inc has a balanced capital structure with a debt-to-equity ratio of 1.01.
    • The company's return on equity and return on assets are below typical thresholds for strong performance in the industrial services sector.
    • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
    • The company's capital expenditures were negative, indicating a reduction in investment in long-term assets.
    • EnBio faces medium liquidity risk due to a negative net cash position after subtracting total debt.
    • The company's dilution risk is assessed as low, with no identified dilution sources.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Revenue grew 11.4% year-over-year to 10.7 billion JPY, demonstrating strong top-line expansion momentum.

    Cash conversion ratio of 4.71 is best-in-class, far surpassing the 0.95 cohort median.

    Revenue CAGR of 11.8% over four years highlights consistent long-term growth trajectory.

    BEAR CASE · 3

    High credit risk flag indicates significant potential for financial distress or default issues.

    Debt-to-equity ratio of 1.01 is more than double the 0.43 cohort median, increasing leverage risk.

    Long-term debt increased to 10.1 billion JPY, rising alongside deteriorating cash flow generation.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-13
    Q4 2025 · Quarter highlights

    Revenue ¥3.42B, +53,2% YoY; Operating income −836,6% YoY.

    Revenue¥3.42B+53,2 % YoY
    Operating income-¥460.0M−836,6 % YoY
    Net income-¥609.0M−506,2 % YoY
    Free cash flow
    EPS
    Operating cash flow
    Financials
    Income statement
    Revenue¥3.42B
    Gross profit¥957.0M
    Operating income-¥460.0M
    Net income-¥609.0M
    Margins
    Gross margin28.0%
    Operating margin-13.5%
    Net margin-17.8%
    FCF margin
    Balance sheet
    Total assets¥21.75B
    Total liabilities¥12.91B
    Total equity¥8.83B
    Cash & equivalents¥3.91B
    Long-term debt¥10.50B
    P&L flow · revenue → net income
    Revenue ¥3.42BOperating costs ¥3.88BTax ¥149.0MNet income ¥609.0M
    Highlights
    • Revenue ¥3.42B, +53,2% YoY
    • Operating income −836,6% YoY
    • Net income −506,2% YoY
    • Net margin -17.8%

    Valuation TTM

    Market price
    ¥723,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥8.49B
    Net cash
    -¥5.02B
    Current ratio
    2.0
    Debt / equity
    1.0
    ROA
    1.9%
    ROE
    4.3%
    Cash conversion
    471.0%
    CapEx / revenue
    -41.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin13,4 %Above P75
    Net Margin14,0 %Above P75
    ROE4,3 %Above median
    Capex / Rev-41,7 %Bottom quartile
    D/E1,01Below median
    Cash Conv4,71Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • EnBio Holdings Inc Market data — financials · 2026-05-27
    • EnBio Holdings Inc Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    6092.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-02-13 12:30 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 3.42B · Net JPY -609.0M
    2025-11-14 12:30 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 3.25B · Net JPY 534.0M
    2025-08-14 09:52 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 2.44B · Net JPY 9.0M
    2025-05-15 12:30 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 2.48B · Net JPY -113.1M
    2025-05-15 12:30 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 10.67B · Net JPY 452.7M
    2025-02-14 12:30 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 2.23B · Net JPY 149.9M
    2024-11-14 12:30 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 2.96B · Net JPY 63.9M
    2024-08-14 12:30 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 3.00B · Net JPY 351.9M
    2024-05-15 12:30 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 2.59B · Net JPY 363.5M
    2024-05-15 12:30 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 9.58B · Net JPY 708.8M
    2023-05-15 12:30 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 8.12B · Net JPY 812.1M
    2022-05-13 12:30 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 8.99B · Net JPY 654.1M
    2021-05-14 12:45 UTCEARNINGSAnnual results — FY 2021 Revenue JPY 6.84B · Net JPY 304.1M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage